Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression

BACKGROUND: Existing research evidence indicates that breast cancer patients have different degrees of cognitive dysfunction after chemotherapy, and polymorphisms in 3 genes (catechol-O-methyltransferase, COMT; apolipoprotein E, APOE; and brain-derived neurotrophic factor, BDNF) have been associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen, Zhao, Jingjing, Ding, Ke, Chao, Herta H., Li, Chiang-Shan R., Cheng, Huaidong, Shen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531203/
https://www.ncbi.nlm.nih.gov/pubmed/32985495
http://dx.doi.org/10.12659/MSM.923567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531203/
https://www.ncbi.nlm.nih.gov/pubmed/32985495
http://dx.doi.org/10.12659/MSM.923567

Ejemplares similares